Sector revisions Bio-Rad Laboratories, Inc. NYSE

Stocks

Market Closed - NYSE 04:10:00 2026-08-20 pm EDT			5-day change	1st Jan Change
365.08 ^USD	+8.33%		-.--%	+17.50%

Sep. 09	Bio-Rad Laboratories, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 03:45 PM
Aug. 07	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	ABBOTT LABORATORIES							25
	MEDTRONIC PLC							24
	CENCORA, INC.							13
	BECTON, DICKINSON AND COMPANY							12
	HOYA CORPORATION							15
	DEXCOM, INC.							25
	MEDLINE INC.							25
	WEST PHARMACEUTICAL SERVICES, INC.							16
	SARTORIUS STEDIM BIOTECH							14
	TERUMO CORPORATION							13
	STERIS PLC							8
	ZIMMER BIOMET HOLDINGS, INC.							21
	SOLVENTUM CORPORATION							13
	FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED							11
	BAXTER INTERNATIONAL INC.							11
	AVANTOR, INC.							15
	ALIGN TECHNOLOGY, INC.							15
	BIO-RAD LABORATORIES, INC.							5
	GLOBUS MEDICAL, INC.							13
	Average							15
	Weighted average by Cap.							19